Fonar Corporation Asset Resilience Ratio
Fonar Corporation asset resilience ratio. Fonar Corporation (FONR) has an Asset Resilience Ratio of 0.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Fonar Corporation to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Fonar Corporation (1987–2025)
Asset resilience ratio of Fonar Corporation from 1987 to 2025. This chart shows how Fonar Corporation's Asset Resilience Ratio has changed over time. Read FONR total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Fonar Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Fonar Corporation balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $121.00K | 0.06% |
| Total Liquid Assets | $121.00K | 0.06% |
Asset Resilience Insights
- Limited Liquidity: Fonar Corporation maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Fonar Corporation Industry Peers by Asset Resilience Ratio
Compare Fonar Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Diagnósticos da América S.A
SA:DASA3 |
Diagnostics & Research | 10.42% |
|
SMO ClinPlus Co. Ltd.
SHE:301257 |
Diagnostics & Research | 15.78% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
|
RHYTHM Biosciences Ltd
AU:RHY |
Diagnostics & Research | 2.74% |
|
Bcal Diagnostics Ltd
AU:BDX |
Diagnostics & Research | 0.00% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
Fonar Corporation Asset Resilience Ratio by Year (1987–2025)
Fonar Corporation asset resilience ratio by year from 1987 to 2025. The table below shows the annual Asset Resilience Ratio data for Fonar Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 0.06% | $120.49K | $216.91 Million | -0.01pp |
| 2024-06-30 | 0.06% | $136.10K | $214.25 Million | +0.05pp |
| 2023-06-30 | 0.02% | $32.80K | $200.58 Million | +0.00pp |
| 2022-06-30 | 0.02% | $32.33K | $199.34 Million | 0.00pp |
| 2021-06-30 | 0.02% | $32.18K | $189.51 Million | 0.00pp |
| 2020-06-30 | 0.02% | $31.88K | $180.26 Million | -11.28pp |
| 2019-06-30 | 11.30% | $15.09 Million | $133.56 Million | -- |
| 2018-06-30 | 0.00% | $0.00 | $118.31 Million | -- |
| 2017-06-30 | 0.00% | $0.00 | $98.76 Million | -- |
| 2016-06-30 | 0.00% | $0.00 | $84.89 Million | -- |
| 2015-06-30 | 0.00% | $0.00 | $76.49 Million | -- |
| 2014-06-30 | 0.00% | $0.00 | $76.79 Million | -- |
| 2013-06-30 | 0.00% | $0.00 | $73.15 Million | -- |
| 2011-06-30 | 0.10% | $32.53K | $31.58 Million | -0.02pp |
| 2010-06-30 | 0.13% | $27.61K | $21.63 Million | +0.05pp |
| 2009-06-30 | 0.08% | $22.65K | $28.36 Million | -2.95pp |
| 2008-06-30 | 3.03% | $1.07 Million | $35.23 Million | -1.77pp |
| 2007-06-30 | 4.80% | $1.98 Million | $41.21 Million | -3.83pp |
| 2006-06-30 | 8.63% | $4.94 Million | $57.23 Million | -3.74pp |
| 2005-06-30 | 12.37% | $9.41 Million | $76.09 Million | -2.04pp |
| 2004-06-30 | 14.40% | $11.12 Million | $77.20 Million | +4.47pp |
| 2003-06-30 | 9.94% | $5.84 Million | $58.75 Million | +2.28pp |
| 2002-06-30 | 7.65% | $5.57 Million | $72.83 Million | +0.51pp |
| 2001-06-30 | 7.15% | $6.09 Million | $85.16 Million | -6.43pp |
| 2000-06-30 | 13.57% | $11.48 Million | $84.60 Million | -7.12pp |
| 1999-06-30 | 20.70% | $20.20 Million | $97.60 Million | +18.19pp |
| 1988-06-30 | 2.51% | $1.10 Million | $43.90 Million | +0.50pp |
| 1987-06-30 | 2.01% | $700.00K | $34.90 Million | -- |
About Fonar Corporation
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company of… Read more